CanStaging+ has been developed as a collaboration between the Northern Ireland Cancer Registry (NICR), the International Agency for Research on Cancer (IARC) and the Union for International Cancer Control (UICC). The tool is designed to help maximise the availability, standardisation and comparability of cancer staging internationally. The tool provides automatic calculation of the international TNM staging classification versions 7 and 8 for a variety of tumour sites – breast, cervix, liver, lung, oesophagus, ovary, pancreas, prostate, skin melanoma and stomach. Colorectal cancer may be staged using the TNM staging versions 5 and 8. Used with the permission of UICC, Geneva, Switzerland. The tool works best in conjunction with the UICC TNM classification book which can be purchased here. The original sources for this material are listed in references.
Developed, designed, and maintained by Morten Ervik (IARC/CSU), Giulio Napolitano (Previously of NICR), Kenneth Yeung (NICR), Colin Fox (NICR), Sinead Hawkins (NICR), Freddie Bray (IARC/CSU), Isabelle Soerjomataram (IARC/CSU), and Anna Gavin (NICR)
The original source for this material is:
This tool has been reproduced with due care. Any inconsistencies with the UICC TNM classification 7th and 8th editions in addition to essential TNM and published errata are unintentional. Neither NICR, IARC nor UICC carry any liability should unforeseen errors emerge. However we would be pleased to receive all comments on any inconsistencies
Thanks: Lisa Ranaghan (NICR), James Brierley (TNM Core Group, UICC)
The Cancer Staging Tool also includes automatic calculation of staging for childhood malignancies. The Tool includes a two-tiered approach as recommended that provides less detailed criteria for registries with limited resources and/or limited data access (Tier 1) and more detailed criteria for better-resourced registries (Tier 2). Tier 2 stage categories may be collapsed to Tier 1 categories to preserve comparability across registries.
The Australian Childhood Cancer Registry (Joanne Aitken, Minal Solanki and Andy Gordon) has a leading role in the development and testing of rules of childhood cancer stage in the Tool.
THIS TOOL IS PROVIDED \"AS IS\" WITHOUT WARRANTY OR CONDITIONS OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OR CONDITIONS OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT.
THE NICR ASSUMES NO RESPONSIBILITY FOR ERRORS OR OMISSIONS IN THIS TOOL.
IN NO EVENT SHALL THE NICR BE LIABLE FOR ANY SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES OF ANY KIND, OR ANY DAMAGES WHATSOEVER (INCLUDING WITHOUT LIMITATION, THOSE RESULTING FROM: (1) RELIANCE ON THE MATERIALS PRESENTED, (2) COSTS OF REPLACEMENT GOODS, (3) LOSS OF USE, DATA OR PROFITS, (4) DELAYS OR BUSINESS INTERRUPTIONS, (5) AND ANY THEORY OF LIABILITY, ARISING OUT OF OR IN CONNECTION WITH THE USE OR PERFORMANCE OF INFORMATION) WHETHER OR NOT THE NICR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
THIS TOOL COULD INCLUDE TECHNICAL OR OTHER INACCURACIES. HOWEVER, IARC/NICR MAKES NO COMMITMENT TO PROVIDE UPDATES.